(Q41391222)

English

The role of methoxymorpholino anthracycline and cyanomorpholino anthracycline in a sensitive small-cell lung-cancer cell line and its multidrug-resistant but P-glycoprotein-negative and cisplatin-resistant counterparts

scientific article published on January 1995

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

The role of methoxymorpholino anthracycline and cyanomorpholino anthracycline in a sensitive small-cell lung-cancer cell line and its multidrug-resistant but P-glycoprotein-negative and cisplatin-resistant counterparts (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

multiple drug resistance

1 reference

based on heuristic

inferred from title

author name string

W T van der Graaf

1

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

N H Mulder

2

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

C Meijer

3

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

E G de Vries

4

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

publication date

1 January 1995

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

345-348

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative cytotoxicities of various morpholinyl anthracyclines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paradoxical increase in DNA cross-linking in a human ovarian carcinoma cell line resistant to cyanomorpholino doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA cross-linking and cytotoxicity of the alkylating cyanomorpholino derivative of doxorubicin in multidrug-resistant cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissociation of antitumor potency from anthracycline cardiotoxicity in a doxorubicin analog.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective inhibition of human ribosomal gene transcription by the morpholinyl anthracyclines cyanomorpholinyl- and morpholinyldoxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensely potent morpholinyl anthracyclines

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitization of drug resistant human ovarian cancer cells to cyanomorpholino doxorubicin (MRA-CN) by modulation of glutathione metabolism.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of multidrug resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel anthracycline analogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical study of MX2 (KRN 8602)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of morpholinyladriamycin analogs and adriamycin on the activities of DNA polymerase alpha and RNA polymerase II of chicken leukemia cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combinedin vitro modulation of adriamycin resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morpholinyl anthracyclines: option for reversal of anthracycline resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of covalent DNA binding of morpholino and cyanomorpholino derivatives of doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo modulation of multi-drug resistance with amiodarone

1 reference

https://pubmed.ncbi.nlm.nih.gov/7828280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S002800050245

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41391222&oldid=2096823178"